StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Cash and cash equivalents by Quarter

Cash and cash equivalents ($M) ($M)

QuarterlyAnnual

AstraZeneca Cash and cash equivalents: $4,893M in Q2 2026, down 30.7% from a year earlier.

Latest, Q2 2026
4,893
Period ended Jun 30, 2026
Change on a year earlier
-30.7%
7,058 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Cash and cash equivalents | 4,893 | 5,711 | 7,058”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Net Debt Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCash and cash equivalents ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20264,893-30.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20267,560+44.6%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20255,711+4.1%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20258,143+69.8%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20257,058+2.1%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20255,230-33.3%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20245,488-6.0%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20244,797-1.5%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20246,916+22.1%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20247,841+25.8%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20235,840-5.3%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20234,871+9.3%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20235,664+17.6%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20236,232+8.2%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20226,166-2.6%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20224,458-36.9%Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Cash and cash equivalents ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-cash-equiv

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.